| Safety of bacteriophage therapy in severe Staphylococcus aureus infection A Petrovic Fabijan, RCY Lin, J Ho, S Maddocks, NL Ben Zakour, ... Nature microbiology 5 (3), 465-472, 2020 | 373 | 2020 |
| Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance MR Davies, MT Holden, P Coupland, JHK Chen, C Venturini, TC Barnett, ... Nature genetics 47 (1), 84-87, 2015 | 171 | 2015 |
| Multiple antibiotic resistance gene recruitment onto the enterohemorrhagic Escherichia coli virulence plasmid C Venturini, SA Beatson, SP Djordjevic, MJ Walker The FASEB Journal 24 (4), 1160-1166, 2010 | 92 | 2010 |
| Analysis of a Streptococcus pyogenes puerperal sepsis cluster by use of whole-genome sequencing NL Ben Zakour, C Venturini, SA Beatson, MJ Walker Journal of clinical microbiology 50 (7), 2224-2228, 2012 | 80 | 2012 |
| Transfer of scarlet fever-associated elements into the group A Streptococcus M1T1 clone NL Ben Zakour, MR Davies, Y You, JHK Chen, BM Forde, ... Scientific reports 5 (1), 15877, 2015 | 73 | 2015 |
| Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone PG Maamary, NLB Zakour, JN Cole, A Hollands, RK Aziz, TC Barnett, ... The FASEB Journal 26 (11), 4675, 2012 | 66 | 2012 |
| Phage therapy for severe bacterial infections: a narrative review AP Fabijan, A Khalid, S Maddocks, J Ho, T Gilbey, I Sandaradura, ... The Medical Journal of Australia 212 (6), 279, 2020 | 64 | 2020 |
| Sequences of two related multiple antibiotic resistance virulence plasmids sharing a unique IS 26-related molecular signature isolated from different Escherichia coli … C Venturini, KA Hassan, P Roy Chowdhury, IT Paulsen, MJ Walker, ... PLoS One 8 (11), e78862, 2013 | 63 | 2013 |
| Biological foundations of successful bacteriophage therapy C Venturini, A Petrovic Fabijan, A Fajardo Lubian, S Barbirz, J Iredell EMBO Molecular Medicine 14 (7), e12435, 2022 | 56 | 2022 |
| The role of streptokinase as a virulence determinant of Streptococcus pyogenes-potential for therapeutic targeting J D McArthur, S M Cook, C Venturini, M J Walker Current drug targets 13 (3), 297-307, 2012 | 52 | 2012 |
| Diversity of P1 phage-like elements in multidrug resistant Escherichia coli C Venturini, T Zingali, ER Wyrsch, B Bowring, J Iredell, SR Partridge, ... Scientific Reports 9 (1), 18861, 2019 | 41 | 2019 |
| Interleukin-17A Contributes to the Control of Streptococcus pyogenes Colonization and Inflammation of the Female Genital Tract AJ Carey, JB Weinberg, SR Dawid, C Venturini, AK Lam, V Nizet, ... Scientific reports 6 (1), 26836, 2016 | 37 | 2016 |
| Westmead Bacteriophage Therapy Team. 2020 A Petrovic Fabijan, RCY Lin, J Ho, S Maddocks, NL Ben Zakour, ... Safety of bacteriophage therapy in severe Staphylococcus aureus infection …, 2020 | 32 | 2020 |
| Characterization of EhaJ, a New Autotransporter Protein from Enterohemorrhagic and Enteropathogenic Escherichia coli DM Easton, M Totsika, LP Allsopp, MD Phan, A Idris, DJ Wurpel, ... Frontiers in microbiology 2, 120, 2011 | 30 | 2011 |
| Acquisition of the Sda1-encoding bacteriophage does not enhance virulence of the serotype M1 Streptococcus pyogenes strain SF370 C Venturini, CY Ong, CM Gillen, NL Ben-Zakour, PG Maamary, V Nizet, ... Infection and immunity 81 (6), 2062-2069, 2013 | 29 | 2013 |
| Whole-genome analysis of extraintestinal Escherichia coli sequence type 73 from a single hospital over a 2 year period identified different circulating clonal groups DR Bogema, J McKinnon, M Liu, N Hitchick, N Miller, C Venturini, J Iredell, ... Microbial genomics 6 (1), e000255, 2020 | 27 | 2020 |
| Effects of antibiotic treatment with piperacillin/tazobactam versus ceftriaxone on the composition of the murine gut microbiota C Venturini, B Bowring, A Fajardo-Lubian, C Devine, J Iredell Antimicrobial Agents and Chemotherapy 65 (2), 10.1128/aac. 01504-20, 2021 | 22 | 2021 |
| Fine capsule variation affects bacteriophage susceptibility in Klebsiella pneumoniae ST258 C Venturini, NL Ben Zakour, B Bowring, S Morales, R Cole, Z Kovach, ... The FASEB Journal 34 (8), 10801-10817, 2020 | 18 | 2020 |
| Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients HKAH Gamage, C Venturini, SG Tetu, M Kabir, V Nayyar, AN Ginn, ... Scientific Reports 11 (1), 7252, 2021 | 13 | 2021 |
| Transfer of scarlet feverassociated elements into the group A Streptococcus M1T1 clone. Sci Rep 5: 15877 NL Ben Zakour, MR Davies, Y You, JH Chen, BM Forde, M Stanton-Cook, ... | 11 | 2015 |
